Talks in the session emphasised diverse stress, reproduction and behaviour-related processes that are all subject to neuroendocrine regulation. This review therefore details advances in our understanding of how key hypothalamic neuropetides and steroid hormones enable the neuroendocrine control of these processes. To maintain the health and well-being of all mammals, numerous aspects of physiology are controlled by neuroendocrine mechanisms. These mechanisms ultimately en- 
by Andrew Shally's group in the 1970s and is now accepted as the central regulator of the endocrine network that drives reproductive functions and behaviours: the hypothalamic pituitary gonadal (HPG) axis. 1, 3 In addition to their involvement in these classical neuroendocrine networks, CRF and GnRH regulate other stress and reproduction-related functions. For example CRF has been implicated in autonomic, behavioural and metabolic activities in response to stress, and GnRH plays a role in reproductive cancer biology. 4, 5 Similar to neuropeptides, steroid hormones are important mediators of neuroendocrine regulation of various physiological functions.
Steroid hormones, including corticosteroids made by the adrenal gland and sex steroids made in the gonads, act on numerous tissues to alter stress, reproduction and behaviour-related processes, amongst others. 6, 7 The discovery of steroid hormone receptors in the brain in the 1960s and 1970s paved the way for studies of steroid hormone effects on brain functions. 8 It is now understood that corticosteroids, such as glucocorticoids, can act within various brain regions to influence stress reactivity, cognition, arousal, memory, mood and behaviour. 6 Similarly, sex steroids, such as testosterone and oestradiol, act throughout the brain to alter stress reactivity, sexual differentiation and sex preference behaviour. 7, 9, 10 Ultimately, dynamic, bidirectional interactions exist between the endocrine and nervous systems that are largely mediated by neuropeptides and steroid hormones. In this review, we specifically detail advances in our understanding of how the stress response and reproduction are controlled by the neuropeptides CRF and GnRH, respectively. Additionally, we present developments in our understanding of how sex steroids influence behavioural sex preference.
As we review the diverse topics presented at the IWNE, we hope to ultimately emphasise the ongoing importance of these neuropeptide and sex hormone mediators in neuroendocrine regulatory mechanisms.
| CONTROL OF THE S TRE SS RE S P ON S E BY CRF
Stress is defined as any real or perceived threat to the well-being of an organism, or its homeostasis, and is induced by factors that fall within 2 broad catergories: physical and psychological stressors.
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Physical stressors involve any external or internal condition that brings physical harm, danger, pain or discomfort. 11 Psychological stressors, alternatively, are factors that result in uncertainty, helplessness or social conflict. 11 In rodents, for example, haemorrhage induces physical stress, whereas restraint predominantly induces psychological stress. 12 Notably, different types of stressors activate varying neural networks to drive physiological responses. 12 The neuropeptide CRF is an important mediator of responses to physical and psychological stressors alike. CRF expressed by hypothalamic neurones is the central regulator of the HPA axis, comprising the endocrine network that ultimately drives hormonal responses to both types of stressors. 12 Furthermore, CRF is an important regulator of autonomic and behavioural responses to varying stressors. 4 In addition to its synthesis by and secretion from neurones of the hypothalamic paraventricular nucleus (PVN), which activates the HPA axis, CRF is expressed throughout the central nervous system. 13 It has notably high expression in the central nucleus of the amygdala (CeA) and the bed nucleus of the stria terminalis (BNST) where it is important for numerous autonomic, immune and behavioural changes during stress. 4 To regulate various aspects of the stress response, CRF and the related peptides, urocortins 1, 2 and 3 all bind to 1 or 2 of 2 types of CRF receptors (CRF 1 and CRF 2 ) with varying affinity. 14 
| Acute physical stressors
The first evidence for the involvement of brain CRF receptors in the control of cardiovascular responses to stress was obtained in a study evaluating cardiovascular responses during treadmill exercise in rats. 17 Intacerebroventricular administration of the nonselective CRF receptor antagonist, α-helical-CRF 9-41 , decreased exerciseinduced elevations of blood pressure, heart rate, mesenteric vascular resistance and iliac blood flow. 17 Additionally, it was reported that the reduced cardiovascular responses in animals treated with the CRF antagonist were followed by compromised function as reflected by the decreased ability of animals to sustain dynamic exercise. 17 These results provided evidence of an important role of brain CRF neurotransmission in the expression of cardiovascular adjustment to dynamic exercise. Other initial studies in rats further supported a role for CRF in mediating cardiovascular responses to physical stressors. Treatment with the nonselective CRF receptor antagonist α-helical-CRF 9-41 attenuated the elevation of plasma epinephrine levels induced by haemorrhage and hypoglycaemia. 18 Furthermore, i.c.v. administration of α-helical-CRF 9-41 decreased hypertension, tachycardia (heart rate exceeding the resting rate) and hyperthermia induced by treatment with interleukin-1β, an important cytokine mediator of the inflammatory response. 19 It was also reported that α-helical-CRF 9-41 decreased the reduction in baroreflex function induced by bilateral hindlimb ischaemia without affecting the pressor and tachycardiac effects. 
| Acute psychological stressors
Endogenous CRF and related peptides also mediate cardiovascular and autonomic changes evoked by psychological stressors. Early studies in rats demonstrated that α-helical-CRF 9-41 given i.c.v. decreased the pressor response, tachycardia and hyperthermia induced by acute cage-switch stress. 19, 21 This cage-switch stress is a mild psychological stressor that is evoked by removing the rat from its home cage and placing it into another identical plastic cage containing water to a depth of 1 cm. 19 Other studies reported evidence of decreased circulating epinephrine and norepinephrine in rhesus monkeys subjected to psychosocial stress (intruder paradigm) and treated orally with the centrally acting, selective CRF 1 receptor antagonist antalarmin. 22 Additionally, α-helical-CRF 9-41 treatment decreased the tachycardiac response to contextual fear conditioning in rats by modulating parasympathetic activity. 23 The effects of nonselective and selective CRF receptor antagonists on tachycardia following auditory fear conditioning, however, were not observed. 24 The results of this study using auditory fear conditioning are difficult to interpret because absolute values rather than changes in heart rate during the conditioned stimulus were analysed. Thus, it is hard to determine by how much the pre-stimulus bradycardia (ie, heart rate below the resting rate) evoked by CRF affected the results obtained during the conditioned stimulus. Nevertheless, the contradicting findings of such fear conditioning studies suggest that the involvement of CRF neurotransmission in cardiovascular changes during conditioned threats may be stimulus-specific.
Although CRF in the CNS enhances cardiovascular responses to many psychological stressors, it can also decrease them depending on the nature of the stressor. For example, i.c.v. administration of the nonselective CRF receptor antagonist d-PheCRF 12-41 increased the bradycardiac responses evoked by airpuff startle stress. 25 Increased bradycardia evoked by swim stress was also reported in rats systemically treated with the centrally acting, selective CRF receptor 1 antagonist antalarmin. 26 These studies suggest that CRF neurotransmission has an inhibitory influence on cardiovascular responses to airpuff startle and swim stressors. However, it is important to note that bradycardia, rather than the typical stress-evoked tachycardia, was reported in these studies. 25, 26 Thus, an inhibitory influence of CRF neurotransmission in bradycardiac responses is well aligned with evidence that CRF increases cardiovascular function by inhibiting parasympathetic activity, which drives bradycardia. 18, 23, 27 Accordingly, the increase in swim stress-evoked bradycardia by antalarmin was completely antagonised by systemic treatment with a peripherally acting cholinergic antagonist, methylatropine nitrate, which inhibits parasympathetic activity. 
| Chronic stressors
CRF neurotransmission in the brain was also reported to be in- Studies directly evaluating sites in the CNS that mediate the control of cardiovascular responses to stress by CRF neurotransmission provided evidence for a role of the DMV and the BNST. 23, 24, 30 A role for the DMV was identified in experiments in which ovine CRF was microinjected into the DMV resulting in decreased tachycardia following auditory fear conditioning in mice. 24 This effect of CRF was dose-dependent and antagonised by pretreatment with the CRF receptor antagonist astressin. 24 The control of cardiovascular responses by CRF neurotransmission within the BNST, on the other hand, appears to be stress-specific. One study reported that microinjection of the nonselective CRF receptor antagonist α-helical-CRF 9-41 into the BNST enhanced the tachycardiac response to contextual fear conditioning, possibly by modulating parasympathetic activity. 23 Conversely, microinjection of selective CRF 1 or CRF 2 receptor antagonists into the BNST dose-dependently decreased the pressor, tachycardiac and sympathetically-mediated cutaneous vasoconstriction responses evoked by acute restraint stress. 30 Taken together, these results indicate that CRF neurotransmission within the BNST plays an inhibitory role in cardiac responses to conditioned aversive stimuli, whereas it plays an excitatory role in the expression of cardiovascular changes in response to unconditioned stimuli.
| CRF and the regulation of the hormonal response to stress
The importance of CRF in directing the hormonal responses to stress has been well recognised subsequent to its characterisation by Vale et al. 2 In the presence of both physical and psychological stressors, CRF markedly increases in and is secreted from PVN neurones, which activates the HPA axis. 2 Upon its secretion into the hypophyseal portal vasculature, CRF stimulates the release of adrenocorticotrophic hormone (ACTH) from the anterior pituitary. 2 ACTH, in turn, induces downstream secretion of glucocorticoids by the adrenal cortex to organise body wide, adaptive responses to stress. 2 Acute elevations in glucocorticoids are beneficial, although unrestrained glucocorticoid levels can lead to stress-related pathologies, such as cardiovascular disease, obesity and major depressive disorder. 6 Thus, PVN CRF expression is tightly controlled by a glucocorticoid negative-feedback loop and represents an important nexus in the control of glucocorticoid production. 34 Substantial evidence suggests that PVN crf is a target of feedback regulation by glucocorticoids. In the rat, removal of most circulating glucocorticoids by adrenalectomy increased PVN CRF mRNA 35 and protein, 36 whereas peripheral administration of glucocorticoids decreased them in adrenalectomised animals. 37 Additionally, glucocorticoid implants in the PVN decreased CRF mRNA levels in adrenalectomised rats, suggesting that glucocorticoids act directly upon PVN CRF neurones to decrease crf expression. 38 Ultimately, CRF is essential in the neuroendocrine mechanisms that limit activation of the HPA axis. Below, details are provided about the advances made in our understanding of how crf expression is regulated by glucocorticoids aiming to shed light on how it may act to keep stress-induced HPA axis activity in check.
| An important role for the glucocorticoid receptor
To decrease PVN CRF expression and prevent the detrimental health consequences of excess glucocorticoids, stress-induced glucocorticoids act through the intracellular glucocorticoid receptor (GR). 39 The GR functions as a nuclear receptor and, accordingly, exists as a cytoplasmic multiprotein complex consisting of 1 receptor molecule and stress-responsive heat shock proteins, including heat shock protein (hsp)90 and hsp70. The binding of glucocorticoids triggers the dissociation of heat shock proteins, multiple phosphorylation steps, nuclear translocation, dimerisation and, ultimately, the increased affinity of the receptor for DNA elements where it can influence gene transcription. 39 Notably, the GR is not the only receptor that can bind glucocorticoids and influence gene transcription.
The mineralocorticoid receptor (MR) is also sensitive to glucocorticoids. 40 However, the limited localisation of the MR in hypothalamic areas and its higher affinity for corticosterone results in its selective occupation by basal glucocorticoid levels. 40 The GR, alternatively, is abundantly expressed in hypothalamic areas, and its lower affinity for corticosterone results in its occupation by stress-induced glucocorticoids. 40 Hence, the GR plays a greater role in mediating glucocorticoid negative-feedback following a stressor.
Within PVN CRF neurones, the ligand-bound GR can directly alter crf transcription. To do so, GR can either (i) bind the crf promoter and recruit transcriptional co-regulators; (ii) interact with other transcription factors and modify their interaction with DNA;
(iii) modify signal transduction pathways; and/or (iv) affect the halflife of CRF transcripts. 4 All mechanisms are important for controlling crf transcription; however, here, we provide details of the advances in our understanding of a direct DNA binding mechanism in which ligand-bound GR recruits co-regulators to the crf promoter. Initial support for these direct actions of GR comes from the localisation of GR immunoreactivity in CRF neurones. 41 Furthermore, the crf promoter contains a negative glucocorticoid response element that mediates repression of crf expression by the GR. 
| A role for methyl-CpG-binding protein (MeCP)2
The mechanism by which DNA-bound GR represses PVN crf is not fully
understood; yet, recent in vitro evidence suggests that GR induces methylation in the crf promoter to facilitate transcriptional repression. 43 Hypermethylation of the crf promoter may allow methyl-CpG binding domain (MBD) proteins to bind and recruit unique sets of co-repressors, such as histone deacetylases to the promoter. 44 A number of MBD proteins have been identified (MeCP1 and MeCP2 and MBD1-4) and all but MBD3 specifically bind to methylated DNA in vitro and in vivo. 44 Most of these MBD proteins could contribute to transcriptional repression of the crf gene; however, MeCP2 is no- 
| Conclusions
The neuropeptide CRF is an essential mediator of the neuroendocrine processes that facilitate body wide coping with various types of stressors. In response to stress, CRF not only activates the HPA axis to drive the hormonal stress response, but also coordinates autonomic, behavioural and metabolic reactions. 4 Here, we particu- CRF is also an important regulator of the hormonal stress response because it is a target of feedback regulation by glucococorticoids. 34 Glucocorticoids produced by the HPA axis in response to stressors feed back to act on numerous brain regions that express CRF. 4 Yet, PVN CRF is a particularly significant target because it is the central regulator of the HPA axis. 4 Without CRF mediating glucocorticoid feedback inhibition, the activity of the HPA axis would largely go unrestrained and result in severe pathological consequences. 6 Thus, understanding how PVN CRF may limit HPA activation certainly warrants further investigation.
Ultimately, these diverse examples highlight the significance of CRF in the neuroendocrine mechanisms that control numerous aspects of stress physiology.
| CONTROL OF REPRODUC TI ON BY G NRH
The neuropeptide GnRH is the pivotal regulator of the endocrine network that drives reproductive function. This network, the HPG axis, is activated by GnRH synthesis in the medial preoptic area and arcute nucleus of the hypothalamus. 47 Following its release from the hypothalamus into the median eminence, GnRH stimulates the synthesis of the gonadotrophins follicle-stimulating hormone (FSH) and luteinising hormone (LH) by the anterior pituitary. 47 These gonadotrophins are released from the pituitary in response to GnRH pulses during the reproductive cycle and act on the gonads to regulate steroid synthesis and gamete production. 47 In females, FSH prompts the growth and maturation of ovarian follicles and stimulates oestrogen secretion; LH induces ovulation, as well as formation of the corpus luteum, and stimulates progesterone secretion. 48 In males, on the other hand, FSH and LH stimulate spermatogenesis and androgen secretion, respectively. 49 Ultimately, GnRH, via its control of the HPG axis, is an important mediator of both the direct and indirect neuroendocrine regulation of reproductive function, as demonstrated in the examples below.
| Direct neuroendocrine regulation by GnRH
GnRH exerts its effects on reproductive functions and behaviours by acting through a receptor that belongs to a large family of G proteincoupled receptors (GPCRs). 49 This GnRH receptor has 7 transmembrane domains and responds to extracellular cues by triggering a cascade of intracellular events to alter neuroendocrine processes such as those regulating reproductive function. 49 
| A GnRH metabolite complicates what we know about GnRH biology
GnRH neuroendocrinology is complicated by the production of a GnRH metabolite that functions independently of the parent peptide. 52 Full-length GnRH is enzymatically metabolised by the zinc metalloendopeptidase EC3.4.24.15 (EP24.15) in the brain and peripheral tissues to generate a pentapeptide, GnRH-(1-5). This metabolite is biologically active with respect to binding the novel GPCRs, GPR173 and GPR101 and may contribute to the normal migration of GnRH neurones during development, as well as cancer biology.
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Thus, GnRH-(1-5) signalling is a topic of great interest because altered GnRH neuronal migration can lead to multiple pathologies, including delayed pubertal onset and infertility. 55 Additionally, GnRH-(1-5) signalling may increase the risk for cancers of the reproductive system. 56 Here, we detail advances in our understanding of GnRH-(1-5) signalling in GnRH neuronal migration during development and cancers.
| GnRH-(1-5) signalling and the migration of developing GnRH neurones
During development, GnRH-secreting neurones originate outside the central nervous system in the nasal region and migrate along the vomeronasal tract traversing the cribiform plate to target the basal forebrain. 57 As these neurones populate the basal forebrain, they send their nerve terminals to the median eminence where, eventually, GnRH is released into the hypophyseal portal system from hypothalamic neurones in a pulsatile manner.
Recent evidence suggests that GnRH-(1-5) binding to GPR173, in particular, is important for regulating GnRH neuronal migration during development. In an immature GnRH neuronal cell line, GN11, GnRH-(1-5) activation of GPR173 inhibited neuronal migration as measured by the in vitro wound closure assay and the Boyden chamber assay. 53 The Thus, GnRH-(1-5) may modulate the migration rate of GnRH neurones into the basal forebrain during development, ensuring that they are positioned properly to make and receive appropriate connections.
| GnRH-(1-5) signalling and cancers of the reproductive system
Although antiproliferative effects of the full-length GnRH have been reported, 5 proliferative effects of GnRH-(1-5) on endometrial cancer cell lines have also been found. 56 The effect of GnRH-(1-5) on these cells is mediated by GPR101, which stimulates phosphorylation of the epidermal growth factor receptor (EGFR) to enhance cell proliferation, as measured by increased cellular migration in an in vitro wound closure assay. 56 To phosphorylate EGFR, GnRH- (1) (2) (3) (4) (5) binds to GPR101 and mobilises matrix metalloproteinase 9, which cleaves membrane bound epidermal growth factor. 56 Although
GnRH-(1-5) signalling through GPR101 has a known role in cancer biology, its normal physiological functions remain under-investigated.
Exploration of GnRH-(1-5) signalling through GPR101 in the brain will be especially important because GPR101 is expressed in many brain regions and has been implicated in numerous neuroendocrinerelated functions. 
| Indirect neuroendocrine regulation by GnRH
GnRH also alters reproductive function indirectly via its regulation of the production of gonadotrophins, FSH and LH. Here, we discuss how FSH may regulate ovarian cell fate, thereby highlighting an indirect role for GnRH in the control of reproductive processes.
| Neuroendocrine regulation of granulosa cell fate
Studies on the neuroendocrine mechansims governing reproductive function have long emphasised a role for the ovary, for which gamete and hormone production is tightly controlled by the nervous system. The ovary is partially controlled by the brain via its regulation of the HPG axis and production of the pituitary hormones FSH and LH. 60 To complement the actions of pituitary hormones, fibres within the sympathetic nervous system also form connections between the hypothalamus and the ovary. 61 Sympathetic nerve fibres are found in most areas of the ovary. However, granulosa cells of the ovarian follicles are an interesting exception because nerve fibres do not cross the basal lamina between the theca and granulosa cell compartments. 62 Thus, pituitary hormones may play an especially predominant regulatory role in the granulosa cells.
The granulosa cell compartment of ovarian follicles hosts the oocyte and changes in size and function dramatically during follicular development and growth. 62 This follicular development process, or folliculogenesis, involves the recruitment of a primordial follicle that grows and develops into a specialised preovulatory follicle that contains a fluid-filled antrum. 62 Importantly, most ovarian follicles never reach the preovulatory stage. Instead, they undergo follicular atresia, which involves death and degeneration of granulosa cells and the oocyte. 62 Because FSH promotes granulosa cell division and subsequent growth of the follicle, this follicular atresia largely occurs during stages with declining FSH concentrations. 63 Thus, FSH is a key determinant in the life and death of ovarian follicles, although the underlying mechanisms are not fully understood.
The growth-stimulating actions of FSH in the avascular compartment of the ovarian follicle may be mediated by a cholinergic system, which has been identified in granulosa cells and implicated in the regulation of their fate (Figure 1) . 64, 65 Evidence suggests that FSH increases activity of this cholinergic system to promote growth in granulosa cells. 66 Thus, an indirect neuroendocrine process in which GnRH regulates FSH, and the ovarian cholinergic system in turn, may be important for controlling granulosa cell fate.
| The ovarian cholinergic system and control of granulosa cell fate
Although acetylcholine (ACh) is classically known for its role in the nervous system, recent studies found that granulosa cells also express the ACh synthesising enzyme (choline acetyltransferase
[ChAT]), produce ACh, and express functional muscarinic ACh receptors. 65, 67, 68 The functions of this ovarian, noncholinergic system were studied in cultured human, in vitro-fertilisation (IVF) derived granulosa cells. Experiments reported muscarinic receptor-mediated elevations in intracellular Ca 2 , transcription factor changes, breakdown of gap junction communication and activation of ion channels. 67, [69] [70] [71] [72] Collectively, these findings suggested that the ovarian cholinergic system mediates trophic, growth-promoting actions in granulosa cells.
Granulosa cells of the human follicle also express the enzyme ACh-esterase (AChE), which inactivates ACh and thus limits its actions. 73 AChE inhibition elevated ACh and thereby enhanced survival of cultured IVF-derived granulosa cells. 74 Several splice variants of AChE were detected in human granulosa cells, including AChE-R, which has been associated with enzymatic and other non-enzymatic actions. 75 Non-enzymatic roles are the result of a unique C-terminal sequence of this AChE splice variant. In granulosa cells administered a synthetic AChE-R peptide, a striking form of cell death was evident. 74 This cell death, termed regulated necrosis, or necroptosis, involved the activation of specific kinases and was distinct from classical apoptosis. 74, 76 Importantly, clear signs of this necroptosis have also been observed in the human and nonhuman primate ovary, supporting its physiological relevance. 74 As is the case for humans, AChE inhibition promotes cell growth in rodents and nonhuman primates. In the rat, ovarian ACh and AChE were readily found. Application of the AChE inhibitor huperzine A to the ovarian bursa increased follicle growth, ovulation and overall fertility. 77 Similarly, huperzine A treatment of 3D-cultures of monkey ovarian follicles improved the growth of small follicles associated with oestradiol production (A. Mayerhofer, unpublished data). To inhibit AChE in all of the species examined, huperzine A acts by binding an allosteric site on AChE to induce a conformational change in its active site and prevent ACh binding and degradation.
| A potential role for FSH
Indirect evidence suggests that FSH increases the activity of the non-neuronal cholinergic system to promote growth in granulosa cells. First, the ACh biosynthesis enzyme, ChAT, was expressed only during follicular stages that depended on the activity of FSH in mice, rats and monkeys. 65, 66 Additionally, cells derived from antral rat follicles that express the FSH receptor had increased ACh production when treated with FSH. 66 Thus, an indirect neuroendocrine process in which GnRH regulates FSH may be important for controlling granulosa cell growth.
| Conclusions
The neuropeptide GnRH is an essential mediator of the neuroendocrine mechanisms underlying various reproduction-related functions. In addition to its regulatory role in the HPG axis, GnRH has been shown to be important for GnRH neuronal migration during development, as well as for cancers of the reproductive system, via the production of its metabolite GnRH-(1,5). Furthermore, recent 
| S TEROID HORMONE REG UL ATI ON OF S E X PREFEREN CE B EHAVI OUR
One of the most obvious behavioural sex differences among animals is sexual partner preference. Males usually select female partners, whereas sexually receptive females regularly prefer males. 78 However, in several species, including humans, there are male individuals that spontaneously prefer same-sex interactions. 79, 80 Given these differences, it has been questioned whether a neuroendocrinology-mediated process determines sex preference in animals and, furthermore, whether such a mechanism is responsible for human sexual orientation. The answers to these questions are highly controversial. Technical issues preclude the analysis of putative prenatal changes in hypothalamic-releasing factors, gonadotrophins and gonadal steroids in animal foetuses that may result in same-sex preference in adulthood. In addition, no endocrine differences have been found between adult male or female homosexuals and their heterosexual counterparts. 81 To date, most of the literature supporting a neuroendocrine hypothesis of sexual preference/orientation refers to the organisational effect of androgens, either directly or via their conversion to oestrogens, in modelling the brain. 82 Here, we provide evidence that sex preference is subject to a neuroendocrine process and that the brains of males that prefer other males differ from those that prefer females. Importantly, we emphasise caution in directly translating these findings to human sexuality. 
| Aromatase inhibitors and sex preference
Sexual differentiation of the male brain relies on foetal/neonatal testosterone exposure, which may have direct effects and/or act via its conversion to oestradiol, to virilise brain structures regulating sex preference, excitement and behaviour. 10 The aromatase enzyme, which converts testosterone to oestradiol, therefore plays a critical role in promoting sexual differentiation druing critical periods in male rats. 83 Studies examining effects of the aromatase enzyme on sex preference behaviour have often used the aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD) to demonstrate that aromatase blockade increases a same-sex preference in males. 84 However, ATD is not the most selective blocker of aromatase activity because it is a steroidal compound that can also bind androgen, oestrogen and progesterone receptors to potentially influence sex preference. 85 Thus, a new third-generation nonsteroidal compound, letrozole, fulfills the need for a selective aromatase inhibitor. 
| Sex preference can be experimentally altered with letrozole
In rats, the effects of prenatal exposure to letrozole on sexual behaviour and partner preference in adulthood have been examined. One study demonstrated that, in male rats, prenatal letrozole decreased male sexual behaviour (ie, recognising and mounting a receptive female) and increased female typical sexual behaviour, such as lordosis, a posture for sexual receptivity. 87 Another study similarly showed that prenatal letrozole treatment induced a same-sex preference in a population (approximately 30%) of adult male rats. 88 The letrozole treated males that preferred other males not only exhibited female sexual behaviour (eg, lordosis when mounted by other males (56%), but also they retained their masculine sexual behaviour (ie, mounts, intromissions and ejacluations) when exposed to sexually receptive females (100%). Collectively, these findings support the possibility that, in males with same-sex preference, the brain areas important for sex preference but not masculine sexual behaviour are demasculinised or even feminised. 
| Brain areas regulating sex preference
Both the sexually dimorphic nucleus of the preoptic area (SDN-POA) and the suprachiasmatic nucleus (SCN) are hypothalamic brain areas that have been associated with sexual preference. However, the best examined of the 2 is the SDN-POA. Destruction of the SDN-POA in male rats and its counterpart in ferrets reverses sexual preferences. 90 Additionally, in sheep, differences exist in the size of an ovine SDN (oSDN) that may underlie same-sex preference. A subpopulation of domestic rams has smaller oSDNs and shows a sexual preference for other rams, even when they can choose between another ram and a receptive ewe. 91 In rams and rodents, the size of the SDN is under the influence of testosterone or oestradiol during development, which may explain differences in adult sex preference. 92, 93 Whether morphological differences underlying sex preference exist in the human hypothalamus that are similar to those described in animals is still under debate. However, support for such morphological differences originates from studies of the interstitial nuclei of the human anterior hypothalamus (INAH1-4), which are considered to be similar to the SDN-POA of the rat. 94 One INAH nucleus in particular, INAH3, has a smaller volume in homosexual men compared to that of heterosexuals, and is similar to that of women. 95 Additionally, differences exist in the human SCN that are related to sex preference. Both the volume of the SCN and number of vasopressin (AVP) expressing neurones within it are higher in homosexual men than in heterosexual men. 
| Aromatase blockade affects brain areas regulating sex preference
In rats, perinatal treatment with ATD, which reverses partner preference in adult males, has also been shown to reduce the volume of the SDN-POA 97 and to increase the number of AVP+ neurones in the SCN. 98 The effects of letrozole on morphological changes in the SDN and SCN have also been explored.
Prenatal treatment with letraozole was found to reduce volume and cell number in both the SDN and SCN, suggesting that inhibition of aromatase produced anatomical changes in areas sensitive to oestradiol during development. Unexpectedly, such a reduction was not linked to a same-sex preference because males with a female or male preference had a similar decrease in SDN and SCN cell number and volume. 99 The discrepancy between these results and those of other experiments may be attributable to several factors, including species and rat strain, as well as the aromatase inhibitor used and its timing of administration. These findings also stress the importance of measuring the size of these and other brain areas in males treated with aromatase inhibitors that retain a female preference. Nevertheless, the use of rats with spontaneous same-sex preference may clarify the possible role of these brain areas in partner preference. 100 For the moment, the relationship between the SDN, SCN, AVP and same-sex preference continues to be an enigma.
| SUMMARY AND CON CLUS I ON S
The topics presented in this session of the IWNE highlight the essential involvement of neuropeptides and/or steroid hormones in the neuroendocrine mechanisms controlling stress, reproduction and behaviour-related functions. The first section of this review therefore examined the role of the neuropeptide CRF in stress physiology.
Specifically, the essential roles of CRF in mediating cardiovascular responses to stress and in the negative-feedback regulation of the HPA axis by glucocorticoids were emphasised. The second section then illustrated the importance of the neuropeptide GnRH for controlling various aspects of reproductive physiology. These included GnRH neuronal migration during development, cancers of the reproductive system and, albeit indirectly, ovarian follicular growth.
Lastly, the third section highlighted the significance of sex steroids during critical developmental windows with respect to determining sex prefence behaviour.
Collectively, the present review illustrates the significance of molecular mediators with respect to the dynamic, bidirectional interactions that occur between the endocrine and nervous systems.
Without neuropeptides, such as CRF and GnRH, and sex steroids, the fine neuroendocrine control of many physiological functions would not occur. Thus, further investigation of the involvement of these molecular players in stress, reproduction and behaviourrelated functions is warranted. 
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